Related Videos
Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma
Matthew Cortese of Roswell Park Comprehensive Cancer Center leads a discussion about frontline management and treatment of relapsed/refractory chronic lymphocytic leukemia and small cell leukemia, joined by Micole Lamanna from Herbert ...
Cellular Therapies Leading to New Treatment Options for Lymphoma Patients
A new CAR T-cell consortium, Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.